Manuel Alós

Analysis of the carbon footprint of pharmacological treatments in advanced chronic kidney disease and peritoneal dialysis: Oral vs. subcutaneous administration

Susana Lomas-Calatayud, Francesc Moncho, Elena Giménez-Civera, María Jesús Puchades et autres

Background Carbon footprint quantification currently stands as the most accepted model for assessing the ecological impact of human activities. Selecting the most environmentally friendly treatment for pathologies arising from advanced chronic kidney disease can reduce the carbon footprint. Methods We aimed to …

es (code pays fourni par la source)

Analysis of the carbon footprint of pharmacological treatments in advanced chronic kidney disease and peritoneal dialysis: Oral vs. subcutaneous administration

Susana Lomas-Calatayud, Francesc Moncho, Elena Giménez-Civera, María Jesús Puchades et autres

BACKGROUND: Carbon footprint quantification currently stands as the most accepted model for assessing the ecological impact of human activities. Selecting the most environmentally friendly treatment for pathologies arising from advanced chronic kidney disease can reduce the carbon footprint. METHODS: We aimed to …

es (code pays fourni par la source)

Atezolizumab Plus Bevacizumab Treatment for Unresectable Hepatocellular Carcinoma: Real-life Experience from a Single Tertiary Centre in Spain and ALBI Score as a Survival Prognostic Factor

María Pilar Ballester, Carlos R. Abril, Víctor Merino, Manuel Alós et autres

Background/Aim: Atezolizumab/bevacizumab (atez/bev) has been established as first-line systemic treatment for hepatocellular carcinoma (HCC). However, concerns regarding safety and efficacy have been raised, and no biomarkers to predict response have yet been identified. We aimed to evaluate the real-life experience of atez/bev …

es (code pays fourni par la source)

Habilidades de comunicación oral y escrita de los futuros profesionales farmacéuticos/as mediante la simulación de casos reales en el aula de Farmacia Comunitaria

María Carmen Recio Iglesias, Isabel García-Arnandis, M. Luisa Ferrándiz, Isabel Andújar et autres

La Farmacia comunitaria forma parte del Sistema Nacional de Salud (SNS) y como tal, comparte con los pacientes, otros profesionales de la salud y las autoridades sanitarias, la misión de garantizar el uso necesario, seguro, efectivo y eficiente de los medicamentos. Aunque …

es (code pays fourni par la source)

5PSQ-058 Efficacy and marginal cost of treatment with tocilizumab in COVID-19 patients

A Garcia, Manuel Alós, R Sanchez, M Anton et autres

Background and importance Pharmacological treatment of SARS-CoV-2 infection focuses primarily on antiviral and immunomodulatory agents. Tocilizumab is a humanised monoclonal antibody that binds to the IL-6 receptor (IL6-R) that has been used to combat the disease. Effectiveness results in controlled trials are …